[go: up one dir, main page]

Hölbling et al., 1982 - Google Patents

Amino Acid Metabolism in Acute Necrotizing Pancreatitis. Aspects of Parenteral Nutrition

Hölbling et al., 1982

Document ID
10572654600083272619
Author
Hölbling N
Funovics J
Roth E
Karner J
Zöch G
Fritsch A
Publication year
Publication venue
Controversies in Acute Pancreatitis

External Links

Snippet

The course of acute necrotizing pancreatitis with primary attack and secondary necrosis includes the clinical signs and therapeutic problems of sepsis. It is well known that the physiological response in sepsis induces a disordered metabolic state (1) and that the …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons

Similar Documents

Publication Publication Date Title
Askanazi et al. Muscle and plasma amino acids following injury: influence of intercurrent infection
ZIEVE Pathogenesis of hepatic coma
Cerra et al. Disease‐specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double‐blind, controlled trial
Coburn et al. Study of intestinal absorption of calcium in patients with renal failure
CN103153298B (en) Materials and methods for improving gastrointestinal function
US9084760B2 (en) Increasing glutathione levels for therapy
Maddrey et al. Effects of keto analogues of essential amino acids in portal-systemic encephalopathy
Raj et al. Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis
US20100298437A1 (en) Use of citrulline for treating undernutrition conditions
US20050158401A1 (en) Treatment and diagnosis of conditions associated with elevated arginase activity
Mc Anena et al. Selective uptake of glutamine in the gastrointestinal tract: confirmation in a human study
Yu et al. A kinetic study of leucine metabolism in severely burned patients. Comparison between a conventional and branched-chain amino acid-enriched nutritional therapy
OKITA et al. Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture
Morrison et al. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched‐chain amino acid administration
Stegink et al. Effects of equimolar doses of L-methionine, D-methionine and L-methionine-dl-sulfoxide on plasma and urinary amino acid levels in normal adult humans
Klassen et al. The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute dengue fever
Schauder et al. Blood levels of branched-chain amino acids and α-ketoacids in uremic patients given keto analogues of essential amino acids
Mansoor et al. Effect of an enteral diet supplemented with a specific blend of amino acid on plasma and muscle protein synthesis in ICU patients
Garibotto et al. Effects of a protein meal on blood amino acid profile in patients with chronic renal failure
Sheng et al. Incorporation of 15NH4Cl into histidine in adult man
WO2022266480A1 (en) Methods of predicting liver fat content and uses thereof
Hölbling et al. Amino Acid Metabolism in Acute Necrotizing Pancreatitis. Aspects of Parenteral Nutrition
Ilchenko et al. HYPERAMMONEMIA IN PATIENTS AT PRE-CIRRHOTIC STAGE: CLINICAL REALITY?
Löfberg et al. Ribosome and free amino acid content in muscle during hemodialysis
Brown et al. Hyperlysinuria with hyperammonemia: a new metabolic disorder